Regeneron's work led to the creation of the VelocImmune mouse. The VelocImmune mouse makes part-human and part-mouse antibodies, which allows the VelocImmune mouse to mount a healthy, functional and ...

Novel in vivo platforms, such as Regeneron's VelocImmune mouse that produced dupilumab, have an edge over those that went before—they produce fully human antibodies while retaining an intact ...

The VelocImmune mouse, which UT Southwestern researchers will use, unlike other human-antibody-producing mice, mounts a robust immune response that is virtually indistinguishable from that of a ...

The antibody cocktail is the result of research by company scientists in which thousands of fully human antibodies produced by Regeneron's proprietary VelocImmune mice were evaluated along with ...

antibodies identified from humans who have recovered from COVID-19 and the company's "VelocImmune" mice, which have been genetically modified to have a human immune system, according to a ...

On Regeneron’s technology platform for speeding drug discovery: The guts of this, the engine, is the VelocImmune mice. This is the brainchild of George Yancopoulos. He wrote about this 35 years ...

To develop REGN-COV2, Regeneron scientists evaluated thousands of fully-human antibodies produced by the company's VelocImmune® mice, which have been genetically modified to have a human immune ...

Immunogenicity led to the discontinuation of clinical development of bococizumab, a murine-derived, humanized antibody to proprotein convertase subtilisin–kexin type 9 (PCSK9), as now described ...

NPR's Ayesha Rascoe asks Li Zhang, professor of physiology and neuroscience at USC's Keck School of Medicine, how mice perform first aid on each other. The instinct to help a fellow creature runs ...

The University of Georgia has been at the forefront of research utilizing transgenic mice. These genetically modified mice are valuable in studying human diseases due to their genetic similarity ...

This modern version, the VelocImmune mouse, is genetically engineered to produce human antibodies for therapeutic use including arthritis and potential treatment for coronavirus infection.